YU31499A - Proces za dobijanje jedinjenja pirolidinil hidroksamske kiseline - Google Patents

Proces za dobijanje jedinjenja pirolidinil hidroksamske kiseline

Info

Publication number
YU31499A
YU31499A YU31499A YU31499A YU31499A YU 31499 A YU31499 A YU 31499A YU 31499 A YU31499 A YU 31499A YU 31499 A YU31499 A YU 31499A YU 31499 A YU31499 A YU 31499A
Authority
YU
Yugoslavia
Prior art keywords
hydroxamic acid
acid compounds
obtaining derivatives
derivatives
obtaining
Prior art date
Application number
YU31499A
Other languages
English (en)
Inventor
Keith Michael Devries
Brian Clement Vanderplas
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU31499A publication Critical patent/YU31499A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Postupak za dobijanje derivativa hidroksamske kiseline koji su primenljivi kao antiinflamatorni ili neuroprotektivni agensi.[Procedure for obtaining derivatives of hydroxamic acid that are applicable as anlgetic, anti inflammatory or neuroprotective agents.
YU31499A 1998-08-24 1999-07-01 Proces za dobijanje jedinjenja pirolidinil hidroksamske kiseline YU31499A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9763398P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
YU31499A true YU31499A (sh) 2002-11-15

Family

ID=22264376

Family Applications (1)

Application Number Title Priority Date Filing Date
YU31499A YU31499A (sh) 1998-08-24 1999-07-01 Proces za dobijanje jedinjenja pirolidinil hidroksamske kiseline

Country Status (18)

Country Link
US (1) US6031114A (sh)
EP (1) EP0982297A3 (sh)
JP (1) JP3245578B2 (sh)
KR (1) KR100338916B1 (sh)
CN (1) CN1245799A (sh)
AR (1) AR016500A1 (sh)
AU (1) AU4466599A (sh)
BR (1) BR9902525A (sh)
CA (1) CA2277242A1 (sh)
HU (1) HUP9901944A3 (sh)
ID (1) ID23462A (sh)
IL (1) IL130429A0 (sh)
IN (1) IN190844B (sh)
PL (1) PL334144A1 (sh)
RU (1) RU2163235C1 (sh)
TR (1) TR199901546A2 (sh)
YU (1) YU31499A (sh)
ZA (1) ZA994285B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508851A (ja) 2001-04-30 2005-04-07 ファイザー・プロダクツ・インク カッパーアゴニストとして有用なヒドロキシピロリジニルエチルアミン化合物の調製方法
AU2003269399A1 (en) * 2002-11-01 2004-05-25 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
US8057664B2 (en) * 2005-11-17 2011-11-15 Exxonmobil Chemical Patents, Inc. Process for reducing bromine index of hydrocarbon feedstocks
US7744750B2 (en) * 2005-11-17 2010-06-29 Exxonmobil Chemical Patents Inc. Process for reducing Bromine Index of hydrocarbon feedstocks
US7517824B2 (en) * 2005-12-06 2009-04-14 Exxonmobil Chemical Company Process for steam stripping hydrocarbons from a bromine index reduction catalyst

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0132001B1 (ko) * 1994-05-21 1998-04-17 강박광 신규한 치환된 이미다졸 유도체
IL117440A0 (en) * 1995-03-31 1996-07-23 Pfizer Pyrrolidinyl hydroxamic acid compounds and their production process
MX9701042A (es) * 1996-02-07 1998-05-31 Pfizer Compuestos del acido hidroxamico.
TNSN97092A1 (ar) * 1996-09-18 1999-12-31 Agouron Pharma مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة.

Also Published As

Publication number Publication date
IL130429A0 (en) 2000-06-01
JP2000072744A (ja) 2000-03-07
EP0982297A2 (en) 2000-03-01
TR199901546A3 (tr) 2000-04-21
AR016500A1 (es) 2001-07-04
AU4466599A (en) 2000-03-09
BR9902525A (pt) 2000-05-02
IN190844B (sh) 2003-08-23
CA2277242A1 (en) 2000-02-24
RU2163235C1 (ru) 2001-02-20
HU9901944D0 (en) 1999-08-30
ZA994285B (en) 2001-01-02
KR100338916B1 (ko) 2002-05-30
JP3245578B2 (ja) 2002-01-15
HUP9901944A3 (en) 2001-10-29
TR199901546A2 (xx) 2000-04-21
KR20000016898A (ko) 2000-03-25
EP0982297A3 (en) 2001-08-01
CN1245799A (zh) 2000-03-01
PL334144A1 (en) 2000-02-28
ID23462A (id) 2000-04-27
HUP9901944A2 (hu) 2000-06-28
US6031114A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
AP9901478A0 (en) Compounds for the treatment of ischemia.
MY133996A (en) Compounds for the treatment of ischemia
DK0915898T3 (da) Krystalform I af clarithromycin
NZ506329A (en) Inhibitors of phospholipase enzymes
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
PL343495A1 (en) Heterocyclically substituted amides used as calpain inhibitors
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
IL149154A0 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA03001463A (es) Derivados de benzofurano o benzotiofeno de aminoalquilbenzoil, metodo para preparar los mismos y composiciones que los contienen.
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
MXPA03001536A (es) (aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
IL152097A0 (en) Use of pyrazole derivatives for treating infertility
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
IL138688A0 (en) Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
BG104575A (en) Matrix metalloprotease inhibitors
YU31499A (sh) Proces za dobijanje jedinjenja pirolidinil hidroksamske kiseline
MY125674A (en) Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
AP2001002045A0 (en) FKBP inhibitors.
IL142776A0 (en) Use of phosphonoformic acid derivatives for treating infections
ID27440A (id) Proses untuk menyiapkan penengah-penengah
AU5794700A (en) Method for determining the fertility of mammals, especially humans
WO2001035951A3 (en) Aryl nitrone therapeutics and methods for treating inflammatory bowel disease
BG107553A (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
SI1077694T1 (en) Aryl nitrone therapeutics for the treatment of inflammatory bowel disease